Center Star Asset Management, LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Center Star Asset Management, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Jul 11, 2022	SELL	$548.35 - $738.84 $438,680 - $591,072	-800 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$595.12 - $698.43 $476,096 - $558,744	800 New	800 $492,000
Q1 2021 Apr 23, 2021	SELL	$446.73 - $548.2 $2.05 Million - $2.52 Million	-4,600 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$478.3 - $607.98 $2.2 Million - $2.8 Million	4,600 New	4,600 $2.51 Million
Q3 2020 Oct 26, 2020	SELL	$544.75 - $658.21 $544,750 - $658,210	-1,000 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$493.32 - $643.92 $394,656 - $515,135	-800 Reduced 44.44%	1,000 $30,000
Q1 2020 Apr 13, 2020	BUY	$336.18 - $494.43 $605,124 - $889,974	1,800 New	1,800 $6,000
Q3 2018 Oct 15, 2018	SELL	$351.14 - $408.51 $1.19 Million - $1.39 Million	-3,400 Closed	0 $0
Q2 2018 Jul 09, 2018	SELL	$284.6 - $344.99 $939,180 - $1.14 Million	-3,300 Reduced 49.25%	3,400 $88,000
Q1 2018 May 01, 2018	BUY	$315.82 - $393.78 $536,894 - $669,426	1,700 Added 34.0%	6,700 $261,000
Q4 2017 Feb 06, 2018	BUY	$358.63 - $469.95 $1.79 Million - $2.35 Million	5,000	5,000 $271,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Center Star Asset Management, LLC with notifications on news.